Non Imprinted in Prader-Willi/Angelman Syndrome 2 (NIPA2) Peptid
NIPA2
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle NIPA2 Produkte
- NIPA2 (Non Imprinted in Prader-Willi/Angelman Syndrome 2 (NIPA2))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- VYITICSVIG AFSVSCVKGL GIAIKELFAG KPVLRHPLAW ILLLSLIVCV
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of NIPA2 antibody, catalog no. 70R-6819
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- NIPA2 (Non Imprinted in Prader-Willi/Angelman Syndrome 2 (NIPA2))
- Synonyme
- RGD1306051 Peptide, fb72g02 Peptide, wu:fb72g02 Peptide, zgc:66088 Peptide, 2600017P10Rik Peptide, 3830408P04Rik Peptide, AB041581 Peptide, non imprinted in Prader-Willi/Angelman syndrome 2 Peptide, non imprinted in Prader-Willi/Angelman syndrome 2 (human) Peptide, non imprinted in Prader-Willi/Angelman syndrome 2 homolog (human) Peptide, NIPA2 Peptide, Nipa2 Peptide, nipa2 Peptide
-
Sie sind hier:
